Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer

OBJECTIVES: We previously reported the feasibility of neoadjuvant capecitabine and oxaliplatin plus bevacizumab as a treatment for locally advanced rectal cancer (UMIN000003219). The aim of this study is to investigate the prognostic relevance of neoadjuvant chemotherapy followed by total mesorectal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Anus Rectum Colon
Autors principals: Nishimura, Junichi, Hasegawa, Junichi, Noura, Shingo, Ikeda, Kimimasa, Yasui, Masayoshi, Komori, Takamichi, Tsujie, Masaki, Yasumasa, Keigo, Shingai, Tatsushi, Uemura, Mamoru, Hata, Taishi, Matsuda, Chu, Mizushima, Tsunekazu, Ikeda, Masataka, Doki, Yuichiro, Mori, Masaki
Format: Artigo
Idioma:Inglês
Publicat: The Japan Society of Coloproctology 2020
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7390618/
https://ncbi.nlm.nih.gov/pubmed/32743112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23922/jarc.2019-042
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars